TISLELIZUMAB (BGB-A317) FOR RELAPSED/REFRACTORY PERIPHERAL T-CELL LYMPHOMAS: SAFETY AND EFFICACY RESULTS FROM A PHASE 2 STUDY

EHA Library, Pier Luigi Zinzani, 293724

CHARACTERIZATION OF CYTOKINE RELEASE SYNDROME AND NEUROLOGICAL EVENTS IN THE PHASE 1 TRANSCEND NHL 001 TRIAL OF LISOCABTAGENE MARALEUCEL FOR PATIENTS WITH RELAPSED/REFRACTORY LARGE B-CELL LYMPHOMA

EHA Library, M. Lia Palomba, 293725

CLONAL HEMATOPOIESIS IN PATIENTS WITH HIGH-GRADE B-CELL LYMPHOMA IS ASSOCIATED WITH INFERIOR OUTCOME

EHA Library, Panagiotis Baliakas, 293726

A WEST-EUROPEAN COHORT OF PATIENTS WITH NK/T-CELL LYMPHOMA, A POPULATION-BASED ANALYSIS.

EHA Library, Jaap Van Doesum, 293727

DDGP, AN EFFECTIVE AND TOLERABLE REGIMEN FOR RELAPSED/REFRACTORY EXTRANODAL NATURAL KILLER/T-CELL LYMPHOMA

EHA Library, 欣 王, 293728

FIBRINOGEN AND FERRITIN MAY HELP TO DETECT SEVERE ICANS AT AN EARLY STAGE AFTER ANTI-CD19 CAR-T CELL THERAPY

EHA Library, Pierre Sesques, 293729

POLATUZUMAB-VEDOTIN IN COMBINATION WITH RITUXIMAB/BENDAMUSTINE IN A GREEK MULTICENTER COHORT OF RELAPSED/REFRACTORY AGGRESSIVE B-CELL-NON-HODGKIN LYMPHOMA PATIENTS:REAL-LIFE DATA ON EFFICACY & SAFETY

EHA Library, Maria Dimou, 293731

APPARENT DIFFUSION COEFFICIENT AS A VALUABLE QUANTITATIVE PARAMETER FOR PREDICTING CLINICAL OUTCOMES IN PATIENTS WITH NEWLY DIAGNOSED PRIMARY CNS LYMPHOMA

EHA Library, Ju-Hyung Kim, 293732

EFFECT OF PRIOR THERAPY ON THE EFFICACY AND SAFETY OF ORAL SELINEXOR IN PATIENTS WITH RELAPSED/REFRACTORY (R/R) DIFFUSE LARGE B-CELL LYMPHOMA (DLBCL): A POST-HOC ANALYSIS OF THE SADAL STUDY

EHA Library, George Follows, 293733

REFLECT REAL-WORLD EVIDENCE: NON-INTERVENTIONAL, PROSPECTIVE STUDY UPDATE ON THE EFFICACY AND SAFETY OF SANDOZ BIOSIMILAR RITUXIMAB FOR THE TREATMENT OF DIFFUSE LARGE B-CELL LYMPHOMA (DLBCL)

EHA Library, Manfred Welslau, 293734

BIOMARKER IDENTIFICATION IN RELAPSED/REFRACTORY NON-GERMINAL CENTER B-CELL–LIKE DIFFUSE LARGE B-CELL LYMPHOMA TREATED WITH ZANUBRUTINIB

EHA Library, Haiyan Yang, 293735

ALX148, A CD47 BLOCKER, IN COMBINATION WITH RITUXIMAB IN PATIENTS WITH RELAPSED/REFRACTORY (R/R) NON-HODGKIN LYMPHOMA (NHL).

EHA Library, Tae Min Kim, 293736

BIANCA: PHASE 2, SINGLE-ARM, GLOBAL TRIAL TO DETERMINE EFFICACY AND SAFETY OF TISAGENLECLEUCEL IN PEDIATRIC/YOUNG ADULT PATIENTS WITH RELAPSED/REFRACTORY B-CELL NON-HODGKIN LYMPHOMA

EHA Library, Veronique Minard-Colin, 293737

THE OPTIMAL DOSE OF PEGYLATED LIPOSOMAL DOXORUBICIN FOR FIRST- LINE TREATMENT OF DIFFUSE LARGE B CELL LYMPHOMA

EHA Library, Shenmiao Yang, 293738

POLATUZUMAB-VEDOTIN COMBINED WITH IMMUNOCHEMOTHERAPY IN R/R PATIENTS WITH DLBCL: A RETROSPECTIVE, NON-INTERVENTIONAL, REAL-LIFE STUDY OF KROHEM, THE CROATIAN COOPERATIVE GROUP FOR HEMATOLOGIC DISEASES

EHA Library, Dino Dujmovic, 293739

CLINICAL OUTCOMES OF PATIENTS WITH ADULT T-CELL LEUKEMIA-LYMPHOMA IN A NON-ENDEMIC METROPOLITAN AREA: A RETROSPECTIVE ANALYSIS OF THE POPULATION-BASED OSAKA CANCER REGISTRY

EHA Library, Shigeo Fuji, 293740

THE PROGNOSTIC SIGNIFICANCE OF HEPATITIS B VIRUS ANTIBODY IN PATIENTS WITH DIFFUSE LARGE B-CELL LYMPHOMA

EHA Library, Shunfeng Hu, 293741

REAL WORLD POPULATION-BASED EXPLORATION OF THE PATHOLOGY SUBTYPING AND TREATMENT-MODALITIES OF DIFFUSE LARGE B-CELL LYMPHOMA IN BELGIUM IN RELATION TO SURVIVAL

EHA Library, Willem Daneels, 293742

TREATMENT OUTCOME OF N/K T-CELL LYMPHOMA IN MEXICAN PATIENTS: A SINGLE THIRD LEVEL CENTER RETROSPECTIVE ANALYSIS

EHA Library, Katheryn Garzón Velásquez, 293743

PRELIMINARY RESULTS OF RESPONSE-ADAPTED STUDY OF IBRUTINIB, TEMOZOLOMIDE, ETOPOSIDE, DOXIL, DEXAMETHASONE, AND RITUXIMAB (TEDDI-R) IN AGGRESSIVE B-CELL LYMPHOMAS WITH SECONDARY INVOLVEMENT OF THE CNS

EHA Library, Mark Roschewski, 293744

PHASE I/II STUDY OF AVADOMIDE (CC-122) IN COMBINATION WITH R-CHOP FOR NEWLY DIAGNOSED DLBCL

EHA Library, Alejandro Martin, 293745

A PHASE IB/II STUDY OF IDASANUTLIN IN COMBINATION WITH OBINUTUZUMAB OR RITUXIMAB IN PATIENTS WITH FOLLICULAR LYMPHOMA OR DIFFUSE LARGE B-CELL LYMPHOMA

EHA Library, Martin Trepel, 293746

SALVAGE TREATMENT WITH HUMANIZED CART CELLS FOR DIFFUSED LARGE B-CELL LYMPHOMA AFTER THE FAILURE OF MURINE ANTI-CD19-CART CELL THERAPY

EHA Library, Shaomei Feng, 293747

RETREATMENT OF PATIENTS WITH REFRACTORY LARGE B CELL LYMPHOMA WITH AXICABTAGENE CILOLEUCEL (AXI-CEL) IN ZUMA-1

EHA Library, Javier Munoz, 293748

SURVIVAL AMONG PATIENTS WITH RELAPSED/REFRACTORY (R/R) DIFFUSE LARGE B-CELL LYMPHOMA (DLBCL) TREATED WITH SINGLE AGENT ORAL SELINEXOR IN THE SADAL STUDY

EHA Library, Marie Maerevoet, 293749

PHASE 2A OPEN-LABEL STUDY OF MT-3724, A NOVEL CD20-TARGETING ENGINEERED TOXIN BODY, IN COMBINATION WITH LENALIDOMIDE (LEN) IN SUBJECTS WITH RELAPSED OR REFRACTORY B-CELL NON-HODGKIN LYMPHOMA (B-NHL)

EHA Library, Roger Waltzman, 293750

CHARACTERISTICS AND CLINICAL SIGNIFICANCE OF GENE MUTATIONS IN RELAPSED OR REFRACTORY PRIMARY MEDIASTINAL B-CELL LYMPHOMA

EHA Library, Yuelu Guo, 293751

FERTILITY AFTER DOSE-ADJUSTED EPOCH-R IN PATIENTS WITH PRIMARY MEDIASTINAL B-CELL LYMPHOMA - UKRAINIAN EXPERIENCE

EHA Library, Yana Stepanishyna, 293752

PATTERNS OF CARE AND CLINICAL OUTCOMES OF PERIPHERAL T-CELL LYMPHOMA IN THE FRONT-LINE SETTING IN FRANCE, THE UNITED KINGDOM, AND GERMANY

EHA Library, Ajibade Ashaye, 293753

CLINICAL CHARACTERISTICS AND SURVIVAL OF EXTRANODAL NATURAL KILLER/T-CELL LYMPHOMA: A SINGLE CENTER 12-YEAR RETROSPECTIVE ANALYSIS.

EHA Library, Jianda Hu, 293754

CORRELATION OF PD-L1 EXPRESSION WITH RESPONSE - PHASE I/II TRIAL OF PEMBROLIZUMAB AND ROMIDEPSIN IN RELAPSED/REFRACTORY PERIPHERAL T-CELL LYMPHOMA

EHA Library, Melody Becnel, 293755

ADVERSE EVENTS AND CLINICAL BURDEN ASSOCIATED WITH CHEMOTHERAPY IN PATIENTS WITH RELAPSED OR REFRACTORY EBV+ PTLD FOLLOWING SOT: A RETROSPECTIVE CHART REVIEW STUDY FROM GERMANY AND FRANCE

EHA Library, Heiner Zimmermann, 293756

TISLELIZUMAB (BGB-A317) FOR RELAPSED/REFRACTORY EXTRANODAL NK/T-CELL LYMPHOMA: PRELIMINARY EFFICACY AND SAFETY RESULTS FROM A PHASE 2 STUDY

EHA Library, Huiqiang Huang, 293757

REAL-WORLD TREATMENT PATTERNS AMONG PATIENTS WITH DIFFUSE LARGE B-CELL LYMPHOMA (DLBCL) TREATED WITH CD19-DIRECTED CHIMERIC ANTIGEN RECEPTOR T-CELL THERAPY (CAR T)

EHA Library, Jessica J Jalbert, 293758

REGN1979 INDUCES TRANSIENT INCREASE IN CYTOKINE LEVELS, T-CELL ACTIVATION, AND CIRCULATING T-CELL REDUCTION, BUT NO SUSTAINED EFFECTS ON T-CELLS OR CYTOKINE RELEASE

EHA Library, Jurriaan Brouwer-Visser, 293759

ZANUBRUTINIB (BGB-3111) IN COMBINATION WITH RITUXIMAB IN PATIENTS WITH RELAPSED/REFRACTORY NON-HODGKIN LYMPHOMA

EHA Library, Jianfeng Zhou, 293760

RITUXIMAB, LENALIDOMIDE AND ACALABRUTINIB (R2A) FOR RELAPSED/REFRACTORY AGGRESSIVE B-CELL LYMPHOMA: INTERIM ANALYSIS REPORTING GOOD TOLERABILITY AND POTENTIAL DURABLE RESPONSE

EHA Library, Youngil Koh, 293761

UTILITY OF THE KYOTO PROGNOSTIC INDEX IN HIGHER-RISK DIFFUSE LARGE B-CELL LYMPHOMA PATIENTS TREATED WITH UPFRONT AUTOLOGOUS STEM CELL TRANSPLANTATION: A SUPPLEMENTARY ANALYSIS OF JCOG0908

EHA Library, Tsutomu Kobayashi, 293762

COMBINATION OF BRENTUXIMAB-VEDOTIN AND IFOSFAMIDE, CARBOPLATIN, ETOPOSIDE (ICE) IN RELAPSED OR REFRACTORY PERIPHERAL T-CELL LYMPHOMA

EHA Library, Zoe Van de Wyngaert, 293763

EPIDEMIOLOGY AND TREATMENT PATTERNS OF HHV-8-NEGATIVE/IDIOPATHIC MULTICENTRIC CASTLEMAN DISEASE IN THE ERA OF INTERLEUKIN-6 DIRECTED THERAPY.

EHA Library, Sudipto Mukherjee, 293764

CAN RADIOTHERAPY BE SAFELY OMITTED IN PATIENTS WITH PRIMARY MEDIASTINAL B-CELL LYMPHOMA WHO ACHIEVE COMPLETE METABOLIC RESPONSE AFTER CHEMOIMMUNOTHERAPY? A RETROSPECTIVE ANALYSIS FROM A SINGLE CENTER.

EHA Library, Ayman Sayyed, 293765

25 CASES OF NEUROLYMPHOMATOSIS, A SINGLE-INSTITUTION EXPERIENCE OVER 13 YEARS; CLINICAL FEATURES, DIAGNOSIS, AND PROGNOSIS

EHA Library, Kentaro Narita, 293766

PROGNOSTIC IMPACT AND CLINICAL FEATURES OF IDH2R172 MUTATED ANGIOIMMUNOBLASTIC T-CELL LYMPHOMA: A MULTICENTER RETROSPECTIVE STUDY

EHA Library, Marcello Riva, 293767

EARLY DEATHS IN CHILDHOOD BURKITT'S LYMPHOMA; A MAJOR CHALLENGE IN DEVELOPING COUNTRIES

EHA Library, Hanafy Hafez, 293768

A DECADE OF REAL-WORLD EXPERIENCE WITH R-CHOP IN DIFFUSE LARGE B CELL LYMPHOMA – IS EFS24 THE GOAL?

EHA Library, Pedro Chorão, 293769

IMPACT OF RELATIVE DOSE INTENSITY ON SURVIVAL IN ELDERLY PATIENTS AGED 80 YEARS AND OLDER WITH DIFFUSE LARGE B-CELL LYMPHOMA.

EHA Library, Shin Lee, 293770

IS THERE AN IMPACT OF THE FIRST-LINE CHEMOTHERAPY REGIMEN ON THE OUTCOME OF HIGH-GRADE B-CELL LYMPHOMA WITH C-MYC REARRANGEMENT (ALONE OR IN COMBINATION WITH BVL-2 AND/OR BCL-6)

EHA Library, Simon Favre, 293771

DA-R-EPOCH AS FRONT-LINE TREATMENT OF ELDERLY PATIENTS WITH HIGH-RISK DIFFUSE LAGRE B-CELL LYMPHOMA (DLBCL): A REAL-LIFE SINGLE-CENTER STUDY

EHA Library, Igor Aurer, 293772

INTERIM RESULTS OF A PHASE 1/2 STUDY OF LONCASTUXIMAB TESIRINE (LONCA) COMBINED WITH IBRUTINIB IN ADVANCED DIFFUSE LARGE B-CELL LYMPHOMA (DLBCL) OR MANTLE CELL LYMPHOMA (MCL)

EHA Library, Julien Depaus, 293773

NEW TRICKS FOR OLD DRUGS: COMBINATION OF RITUXIMAB, ALBUMIN-BOUND PACLITAXEL AND PEGYLATED LIPOSOMAL DOXORUBICIN IN THE TREATMENT OF RELAPSED/REFRACTORY DIFFUSE LARGE B CELL LYMPHOMA

EHA Library, Liang Wang, 293774

AUTOLOGOUS 4-1BB-CART THERAPY FOR B CELL LYMPHOMA AND MULTIPLE MYELPMA WITH CENTRAL NERVOUS SYSTEM INVOLVEMENT

EHA Library, Peihao Zheng, 293775

LENALIDOMIDE-RITUXIMAB IN HIGH RISK RELAPSED/REFRACTORY DIFFUSE LARGE B CELL LYMPHOMA: A SINGLE INSTITUTION EXPERIENCE

EHA Library, Diego Conde-Royo, 293776

POST-TRANSPLANT LYMPHOPROLIFERATIVE DISORDER POST SOLID ORGAN TRANSPLANT – A HETEROGENOUS, AGGRESSIVE DISORDER: A MULTICENTRE REPORT

EHA Library, Laura Mcdonald, 293777

PLACE OF ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION IN PATIENTS WITH T-CELL LYMPHOMAS: PAVLOV UNIVERSITY RETROSPECTIVE STUDY

EHA Library, Elena Lepik, 293778

DIFFUSE LARGE B CELL LYMPHOMA (DLBCL) AND THE RISK OF CENTRAL NERVOUS SYSTEM (CNS) RELAPSE: A REVIEW FROM THE RITUXIMAB (RTX) ERA

EHA Library, Joana Vieira, 293779

GENETICALLY DEFINED SUBTYPES OF DLBCL FROM TARGETED PANEL ON PLASMA MATCH PREVIOUSLY DESCRIBED TUMOR TISSUE SUBTYPES

EHA Library, Ehsan Tabari, 293781

VALUE OF GENETIC ANALYSIS FOR THE DIAGNOSTIC WORKFLOW OF MATURE CD5 NEGATIVE B-CELL NEOPLASMS ASSOCIATED WITH SPLENOMEGALY

EHA Library, Constance Baer, 293782

GENOME-WIDE CRISPR LIBRARY SCREENING IDENTIFIES GENETIC VULNERABILITIES AND THERAPEUTIC TARGETS IN ADULT T-CELL LEUKEMIA/LYMPHOMA

EHA Library, Takashi Ishio, 293783

ASSESSMENT OF CIRCULATING TUMOR DNA IN PATIENTS WITH RELAPSED/REFRACTORY HODGKIN LYMPHOMA: EARLY IDENTIFICATION OF PATTERN OF MUTATIONS ASSOCIATED WITH RESPONSE OR RESISTANCE TO PD-1 INHIBITORS

EHA Library, Carmelo Carlo-Stella, 293784

SINGLE-CELL RNA-SEQ REVEALS IMMUNE ESCAPE AND DRUG RESISTANCE MECHANISM OF MANTLE CELL LYMPHOMA

EHA Library, Liang Wang, 293785

TUMOR MICROENVIRONMENT AND ELEVATED IL6 ARE ASSOCIATED WITH SEVERE TOXICITY IN PATIENTS WITH LBL TREATED WITH AXICABTAGENE CILOLEUCEL

EHA Library, Rawan Faramand, 293786

SUCCESSFUL EMPLOYMENT OF SPATIAL IMAGING MASS CYTOMETRY IN FOLLICULAR LYMPHOMA CONFIRMS A CENTRAL ROLE OF FOLLICULAR HELPER T-CELLS IN DISEASE PATHOGENESIS AND HAS UTILITY IN PREDICTING OUTCOME

EHA Library, Elizabeth Phillips, 293787

STANDARDIZED 26-PARAMETER FLOW CYTOMETRY FACILITATES UNSUPERVISED WHO CLASSIFICATION OF B-CELL NON HODGKIN´S LYMPHOMA: RESULTS FROM A COMPREHENSIVE MULTICENTER ANALYSIS BY THE EUROFLOW CONSORTIUM

EHA Library, Sebastian Böttcher, 293788

CYCLIN D2 OVEREXPRESSION DRIVES B1-LIKE MURINE MANTLE CELL LYMPHOMA

EHA Library, Tim Pieters, 293789

CD20-TCB INDUCES T-CELL ACTIVATION AND T-CELL-MEDIATED TUMOR CELL KILLING IN PATIENTS WITH RELAPSED OR REFRACTORY NON-HODGKIN LYMPHOMA: BIOMARKER RESULTS FROM A PHASE I STUDY

EHA Library, Ann-Marie E. Bröske, 293790

VALIDATION OF GENE EXPRESSION SIGNATURES IN DIFFUSE LARGE B-CELL LYMPHOMA

EHA Library, Jessica Plaça, 293791

MUTATIONAL PROFILE IN NEWLY DIAGNOSED FOLLICULAR LYMPHOMA AND CORRELATION WITH OUTCOME AFTER TREATMENT WITH INMUNOCHEMOTHERAPY

EHA Library, Conchi Fernández Rodríguez, 293792

TP53-DEPENDENT RESISTANCE TOWARDS CHEMOIMMUNOTHERAPY OF B-CELL LYMPHOMA IS MEDIATED BY ALTERED FORMATION OF EXTRACELLULAR VESICLES AND EXOSOMAL PD-L1 EXPRESSION

EHA Library, Elena Izquierdo Álvarez, 293793

GENOMIC ANALYSIS OF DIFFUSE LARGE B CELL LYMPHOMA WITH SECONDARY CENTRAL NERVOUS SYSTEM INVOLVEMENT.

EHA Library, Joel Wight, 293794

INCORPORATION OF NGS IN CLINICAL PRACTICE IN PATIENTS WITH DLBCL AND FL USING TUMOR AND CTDNA SAMPLES

EHA Library, Bastos Oreiro, 293795

DROPLET DIGITAL PCR FOR NON-INVASIVE MUTATIONAL SCREENING IN WALDENSTRÖM MACROGLOBULINEMIA AND IGM-MGUS: FIRST RESULTS OF THE FONDAZIONE ITALIANA LINFOMI (FIL) BIO-WM TRIAL

EHA Library, Simone Ferrero, 293796

INCREASING ANTIBODY-DEPENDENT LYMPHOMA CELL CLEARANCE BY MACROPHAGESTHROUGH INHIBITION OF THE PENTOSE-PHOSPHATE-PATHWAY

EHA Library, Anna Beielstein, 293797

SINGLE-CELL IMMUNE PROFILING PATIENTS (PTS) WITH RELAPSED/REFRACTORY (R/R) B-CELL NON-HODGKIN'S LYMPHOMA (NHL) TREATED WITH IBRUTINIB (IBR) + NIVOLUMAB (NIVO)

EHA Library, Tatiana Perova, 293798

TARGETING ANTI-APOPTOTIC MCL1 PROTEIN WITH S63845 IS HIGHLY EFFECTIVE IN AGGRESSIVE B-CELL NON-HODGKIN LYMPHOMAS WITH NON-EXPRESSION OF BCL2

EHA Library, Magdalena Klanova, 293799

UNRAVELING THE LANDSCAPE OF COPY NUMBER ABERRATIONS IN HODGKIN LYMPHOMA: A JOINT KULEUVEN AND LYSA STUDY ON CELL-FREE CIRCULATING DNA

EHA Library, Lieselot Buedts, 293800

DUOHEXABODY®-CD37 SHOWS POTENT ANTI-TUMOR ACTIVITY IN PRE-CLINICAL B-CELL LYMPHOMA MODELS IN VITRO AND IN VIVO

EHA Library, Marije B. Overdijk, 293801

DIFFERENTIAL ACTIVATION OF THE B-CELL RECEPTOR (BCR) SIGNALING PATHWAY BY RITUXIMAB AND OBINUTUZUMAB

EHA Library, Jennifer Edelmann, 293802

HETEROGENEOUS EVOLUTION OF DIFFUSE LARGE B CELL LYMPHOMA UNDER TREATMENT WITH A NEW HDAC INHIBITOR LAQ824 AND THE MECHANISM STUDY OF DRUG RESISTANCE

EHA Library, Hui Jin, 293803

A NOVEL LONG NONCODING RNA ENST00000503502 PROMOTES T CELL LYMPHOMA AGGRESSIVENESS BY ACTIVATING TGF-Β SIGNALING PATHWAY

EHA Library, Ping Zhao, 293804

HIGHLY SPECIFIC CYTOTOXIC EFFECT OF T22-DITOX-H6 NANOPARTICLE IN CXCR4+ DIFFUSE LARGE B-CELL LYMPHOMA CELLS

EHA Library, Aïda Falgàs, 293805

CYTARABINE CONTAINING NANOTHERAPEUTICS FOR EXPERIMENTAL THERAPY OF MANTLE CELL LYMPHOMA

EHA Library, Pavel Klener, 293806

LYNX (LYMPHOID NGS): A VERSATILE NGS PANEL FOR COMPREHENSIVE ANALYSIS OF MOLECULAR MARKERS WITH CLINICAL RELEVANCE IN LYMPHOPROLIFERATIVE DISORDERS

EHA Library, Veronika Navrkalova, 293807

THE C-GAS-STING IMMUNE RESPONSE PATHWAY IS ACTIVATED AND PARTIALLY REGULATED BY SAMHD1 IN CLASSICAL HODGKIN LYMPHOMA

EHA Library, Ioanna Xagoraris, 293808

CENTRAL ROLE OF MORAXELLA CATARRHALIS RPOC AND MID/HAG IN NODULAR LYMPHOCYTE-PREDOMINANT HODGKIN LYMPHOMA

EHA Library, Lorenz Thurner, 293809

EPIGENETIC REGULATION OF HGF/C-MET SIGNALING PATHWAY CONFERS AGGRESSIVENESS IN LYMPH NODE ADULT T-CELL LEUKEMIA/LYMPHOMA

EHA Library, Haruhito Totani, 293810

MANTLE CELL LYMPHOMA CELL SURVIVAL RELIES ON HIGH ACTIVITY OF PROTEIN KINASE CK1 ALPHA: IMPLICATIONS FOR BCR INHIBITORS RELATED THERAPY

EHA Library, Sabrina Manni, 293811

OVEREXPRESSION OF PD-1 ON PERIPHERAL T LYMPHOCYTES WAS CORRELATED TO INFLAMMATORY PHENOTYPE OF TUMOR MICROENVIRONMENT AND PREDICTED DISMAL OUTCOME IN DIFFUSE LARGE B-CELL LYMPHOMA

EHA Library, Xiao Li, 293812

CHARACTERIZATION OF ASTX660, AN ANTAGONIST OF CIAP1/2 AND XIAP, IN MOUSE MODELS OF T CELL LYMPHOMA

EHA Library, George Ward, 293813

LNCRNA BCYRN1 MEDIATES L-ASPARAGINASE RESISTANCE THROUGH ENHANCEMENT OF AUTOPHAGY IN NATURAL KILLER/T-CELL LYMPHOMA

EHA Library, Liang Wang, 293814

COMPREHENSIVE ASSESSMENT OF MOLECULAR MARKERS OF SELINEXOR RESPONSE IN PATIENTS WITH DIFFUSE LARGE B-CELL LYMPHOMA (DLBCL)

EHA Library, Christopher Walker, 293815

THE EFFICACY OF OBINUTUZUMAB RETREATMENT IN OBINUTUZUMAB-INDUCED DIRECT CELL DEATH RESISTANT CD20-POSITIVE NON-HODGKIN LYMPHOMA MODEL

EHA Library, Takaaki Fujimura, 293816

EVALUATION OF PHARMACODYNAMIC BIOMARKERS OF EPCORITAMAB (GEN3013; CD3XCD20): RESULTS FROM A PHASE 1/2 DOSE-ESCALATION STUDY IN PATIENTS WITH RELAPSED/REFRACTORY B-CELL NON-HODGKIN LYMPHOMA

EHA Library, Christopher Chiu, 293817

CELL-OF-ORIGIN CLASSIFICATION IN DIFFUSE LARGE B-CELL LYMPHOMAS : PROGNOSIS BY IMMUNOCHEMISTRY (HANS) AND GENE EXPRESSION PROFILING (LST RNA ASSAY NANOSTRING™) IN A FRENCH RETROSPECTIVE COHORT

EHA Library, Gauthier Decool, 293818

NM23-H1: A LEUKAEMIA AND LYMPHOMA DERIVED MESSENGER THAT ALTERS THE TUMOUR MICROENVIRONMENT BY ACTING AS A TUMOUR-ASSOCIATED MOLECULAR PATTERN (TAMP) AND ACTIVATING THE ALTERNATIVE NLRP3 INFLAMMASOME

EHA Library, Sandro Trova, 293819

HIGH THROUGHPUT T CELL RECEPTOR PROFILING IN SYSTEMIC ANAPLASTIC LARGE CELL LYMPHOMA PROVIDES A NOVEL DEEPER INSIGHT INTO THE CHARACTERISTICS OF THE MALIGNANT POPULATION

EHA Library, Vasileios Bikos, 293820

A NOVEL CIRCULAR RNA 0066971 INHIBIT EPSTEIN BARR VIRUS–POSITIVE DIFFUSE LARGE B-CELL LYMPHOMA AGGRESSIVENESS BY SUPPRESSING RAS SIGNALING PATHWAY

EHA Library, Chenxing Zhao, 293821

EXPRESSION OF THE NOVEL TUMOR SUPPRESSOR SAMHD1 IS AN INDEPENDENT, ADVERSE PROGNOSTIC FACTOR IN CLASSICAL HODGKIN LYMPHOMA

EHA Library, Ioanna Xagoraris, 293822

EXPLORATION OF MEASURABLE RESIDUAL DISEASE IN STEM CELL PRODUCTS IN MANTLE CELL LYMPHOMA USING NEXT-GENERATION SEQUENCING

EHA Library, Lea A. L. Elkjær, 293823

A TARGETED DRUG SCREEN REVEALS POTENT INHIBITORS OF T-PLL PRIMARY PATIENT CELLS

EHA Library, Sanna Timonen, 293824

THE IRON CHELATOR DEFERASIROX INDUCES APOPTOSIS AND SYNERGIZES WITH IBRUTINIB IN MANTLE CELL LYMPHOMA

EHA Library, Aladin Samara, 293825